Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BP101 in Healthy Volunteers

Clinical trial NCT03102489 · COMPLETED

Trial details

NCT number

NCT03102489

Sponsor

Ivix LLX

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-02-22

Primary completion

2017-06-21

Enrollment

18

View on ClinicalTrials.gov